Medicine
Sutent 50 mg capsule
Sutent 50 mg capsule is a prescription medicine containing Sunitinib for oral use, marketed by Pfizer Laboratories, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C…
Key facts
- Active ingredient (INN)
- Sunitinib
- Brand
- Sutent
- Strength
- 50 mg
- Dosage form
- Capsule
- Route
- Oral
- Packs
- 28 capsules
- Marketing authorisation holder
- Pfizer Laboratories
- Manufacturer
- Pfizer Laboratories
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C (59°F to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L01EX01 Sunitinib
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 26 January 2006
- Identifiers
- RxCUI 616279, 616283, 616285 +5DailyMed set ID 43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9cNDC 0069-0980Application NDA021938
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 28 capsule in 1 bottle | 0069-0980-38 | Pfizer Laboratories | 26 January 2006 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Sunitinib 50 mg capsule.
Other strengths and forms of Sunitinib
Clinical summary
Sunitinib is a kinase inhibitor indicated for treatment of adult patients with gastrointestinal stromal tumor (GIST) after disease progression on or intolerance to imatinib mesylate, among other approved uses. It is available as capsules for oral use. MedsAcross supplies Sunitinib for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about SunitinibFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- SUTENT prescribing information (Pfizer Laboratories) · U.S. National Library of Medicine, DailyMed
- Sutent: European public assessment report (EPAR) · European Medicines Agency
- Sunitinib Accord: European public assessment report (EPAR) · European Medicines Agency
Need Sutent 50 mg capsule for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.